Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fengreqing oral liquid vs Yinhuang oral liquid for acute upper respiratory tract infection
ChiCTR2300068969Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Fengreqing oral liquid in upper respiratory infection (URI) (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Recovery rate and Pharyngeal pain disappearance rate. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
Fengreqing oral liquid
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2300068969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068969.